The gap between evidence-based medicine and daily practice in the management of paediatric asthma. A pharmacy-based population study from the Netherlands

European Journal of Clinical Pharmacology

Volumn 62, Issue 1, 2006, Pages 51-55

  De Vries, Tjalling W ^a   Tobi, Hilde ^b   Schirm, Eric ^b   Van Den Berg, Paul ^b   Duiverman, Eric J ^c   De Jong van Den Berg, Lolkje T W ^b  

^a MEDICAL CENTER LEEUWARDEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Adherence; Asthma; Guidelines; Pharmacy

Indexed keywords

ANTIASTHMATIC AGENT; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DEPTROPINE; FENOTEROL; FLUTICASONE; FORMOTEROL; IPRATROPIUM BROMIDE; KETOTIFEN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LONG ACTING DRUG; MONTELUKAST; NEDOCROMIL; SALBUTAMOL; SALMETEROL; SHORT ACTING DRUG; TERBUTALINE;

ADOLESCENT; ARTICLE; ASTHMA; CHILD; CLINICAL PRACTICE; CLINICAL PROTOCOL; DRY POWDER; EVIDENCE BASED MEDICINE; HUMAN; MAJOR CLINICAL STUDY; METERED DOSE INHALER; NETHERLANDS; NEWBORN; PEDIATRICS; POPULATION RESEARCH; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; CHILD, PRESCHOOL; DRUG UTILIZATION REVIEW; EVIDENCE-BASED MEDICINE; FEMALE; GUIDELINE ADHERENCE; HUMANS; INFANT; INFANT, NEWBORN; MALE; METERED DOSE INHALERS; NETHERLANDS; PRACTICE GUIDELINES; PRACTICE GUIDELINES AS TOPIC;

EID: 30844433783     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-005-0065-z     Document Type: Article

References (31)

1. Altman DG, Machin D, Bryant TN, Gardner MJ (2000) Statistics with confidence. BMJ Books
2. Anonymous (1997) Asthma in adults and schoolchildren. The General Practitioner in Asthma Group, the British Association of Accident and Emergency Medicine, The British Paediatric Respiratory Society and the Royal College of Paediatrics and Child Health. Thorax 52(suppl 1):s2-s8
3. Anonymous (1997) Asthma in children under five years of age. The General Practitioner in Asthma Group, the British Association of Accident and Emergency Medicine, The British Paediatric Respiratory Society and the Royal College of Paediatrics and Child Health. Thorax 52(suppl 1):s9-s20
4. Anonymous (2004) ATC classification index with DDDs. WHO Collaborating Centre for Drug Statistics Methodology, Oslo, January
5. de Baets F, van Daele S, Franckx H, Vinaimont F (1998) Inhaled steroids compared with disodium cromoglycate in preschool children with episodic viral wheeze. Pediatr Pulmonol 25:361-366
6. Beimfohr C, Maziak, W, Von Mutius E, Hense HW, Leupold W, Hirsch T, Keil U, Weiland SK (2001) The use of antiasthmatic drugs in children: results of a community-based survey in Germany. Pharmacoepidemiol Drug Saf 10:315-321
7. Cabana MD, Rand CS, Becher OJ, Rubin HR (2001) Reasons for pediatrician nonadherence to asthma guidelines. Arch Pediatr Adolesc Med 155:1057-1062
8. Child F, Davies S, Clayton S, Fryer AA, Lenney W (2002) Inhaler devices for asthma: do we follow the guidelines? Arch Dis Child 86:176-179
9. Dashash NA, Mukhtar SH (2003) Prescribing for asthmatic children in primary care. Are we following guidelines? Saudi Med J 24:507-511
10. Dirksen WJ, Geijer RMM, de Haan M, Koning G, Flikweert S, Kolnaar BGM (1998) Guidelines for the treatment of asthma by general practitioners. Huisarts Wet 41:103-143
11. Global Initiative for Asthma (GINA) (2002) Global strategy for asthma management and prevention. National Institutes of Health. National Heart, Lung, and Blood Institute. Bethesda, MD
12. Haby MM, Powell CV, Oberklaid F, Waters EB, Robert CF (2002) Asthma in children: gaps between current management and best practice. J Paediatr Child Health 38:284-289
13. Hoekstra MO (1997) Medical treatment of asthma in children; revised guidelines by paediatric pulmonologists. Ned Tijdschr Geneeskd 141:2223-2228
14. de Jong-Van den Berg LTW, Feenstra N, Sorensen HT, Cornel MC (1999) Improvement of drug exposure data in a registration of congenital anomalies. Pilot-study: pharmacist and mother as sources for drug exposure data during pregnancy. EuroMAP Group. European Medicine and Pregnancy Group. Teratology 60:33-36
15. Kamps AW, van Ewijk B, Roorda RJ, Brand PL (2000) Poor inhalation technique, even after inhalation instructions, in children with asthma. Pediatr Pulmonol 29:39-42
16. Klungel OH, de Boer A, Paes AHP, Herings RMC, Seidell JC, Bakker A (1999) Agreement between self-reported antihypertensive drug use and pharmacy records in a population-based study in the Netherlands. Pharm World Sci 21:218-220
17. Mutius von E (2003) Epidemiology of allergic diseases. In: Leung DYM, Sampson HA, Geha RS, Szefler SJ (eds) Pediatric allergy, practice and principles. Mosby, St. Louis, pp 1-9
18. Monster TBM, Janssen WMT, de Jong PE, de Jong-van den Berg LTW (2002) Pharmacoepidemiol Drug Saf 11:379-384
19. Ng Man Kwong G, Proctor A, Billings C, Duggan R, Das C, Whyte MKB, Powell CVE, Primhak R (2001) Increasing prevalence of asthma diagnosis and symptoms in children is confined to mild symptoms. Thorax 56:312-314
20. Pedersen S (1994) Inspiratory capacity through Turbuhaler in various patient groups. J Aero Med 7:S55S-S58S
21. Schirm E, Monster TBM, De Vries R, Van den Berg PB, de Jong-van den Berg LTW, Tobi H (2004) How to estimate the population that is covered by community pharmacies? An evaluation of two methods using drug utilisation information. Pharmacoepidemiol Drug Saf 13:173-179
22. Shiffman, RN, Freudigman A, Brandt CA, Liaw Y, Navedo DD (2000) A guideline implementation system using handheld computers for office management of asthma: effects on adherence and patient outcomes. Pediatrics 105:767-773
23. Smeele IJM, Grol RPTM, Van Schayck CP, Van den Bosch WJHM, Van den Hoogen HJM, Muris JWM (1999) Can small group education and peer review improve care for patients with asthma/chronic obstructive pulmonary disease? Qual Health Care 8:92-98
24. Sookaneknu P, Richards RME, Sanguansermsri J, Teerasut C (2004) Pharmacist involvement in primary care improves hypertensive patient clinical outcomes. Ann Pharmacother 38:2023-2028
25. Strachan DP (1995) Epidemiology. In: Silvermann M (ed) Childhood asthma and other wheezing disorders. Chapman & Hall, London, pp 7-31
26. Tobi H, van den Berg PB, de Jong-van den Berg LTW (2000) The InterAction database: synergy of science and practice in pharmacy. Lect Notes Comput Sci 1933:206-211
27. Tobi H, van den Heuvel NJN, de Jong-van den Berg LTW (2004) Does uncollected medication reduce the validity of pharmacy dispensing data? Pharmacoepidemiol Drug Saf 13:497-500
28. Van Schayck CP, Smit HA (2005) The prevalence of asthma in children: a reversing trend. Eur Resp J 26:647-650
29. Veninga CCM, Lagerlov P, Wahlstroem R, Muskova, Denig P, Berkhof J, Kochen MM, Haaijer-Ruskamp FM (1999) Evaluating an educational intervention to improve the treatment of asthma in four European countries. Am J Respir Crit Care Med 160:1254-1262
30. Verberne AAPH, Frost C, Roorda RJ, Van der Laag J, Kerrebijn KF, The Dutch Paediatric Asthma Study Group (1997) One year treatment with salmeterol compared with beclomethasone in children with asthma. Am J Respir Crit Care Med 156:688-695
31. Warner JO (2003) Guidelines for treatment of asthma. In: Leung DYM, Sampson HA, Geha RS, Szefler SJ (eds) Pediatric allergy, practice and principles. Mosby, St. Louis, pp 350-356